Bertrand Coiffier, MD from the Centre Hospitalier Lyon-Sud, Pierre-Bénite, France discusses the session on the biosimilar rituximab held at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain. Prof. Coiffier explains some of the key topics discussed during the session, including the advantages of using biosimilars in practice, the rationale for their development biosimilars and the clinical evidence to date.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates